Meropenem-aggravated seizure activity in progressive myoclonus epilepsy

International Journal of Antimicrobial Agents

Volumn 31, Issue 2, 2008, Pages 177-179

  Baraboutis, Ioannis G ^a   Marangos, Markos N ^b   Skoutelis, Athanasios ^b   Bassaris, Haralambos ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; DIAZEPAM; MEROPENEM; METRONIDAZOLE; PHENYTOIN; PROPOFOL; TEICOPLANIN; VALPROIC ACID; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; CASE REPORT; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MYOCLONUS EPILEPSY; PNEUMONIA; PRIORITY JOURNAL; RASH; SEIZURE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; SEIZURES; THIENAMYCINS;

EID: 37549058001     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.09.011     Document Type: Letter

References (9)

1. Delgado-Escueta A.V., Ganesh S., and Yamakawa K. Advances in the genetics of progressive myoclonus epilepsy. Am J Med Genet 106 (2001) 129-138
2. de Sarro A., Ammendola D., Zappala M., Grasso S., and de Sarro G.B. Relationship between structure and convulsant properties of some β-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother 39 (1995) 232-237
3. Norrby S.R., Newell P.A., Faulkner K.L., and Lesky W. Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. J Antimicrob Chemother 36 Suppl. A (1995) 207-223
4. Sieger B., Berman S.J., Geckler R.W., Farkas S.A., and Meropenem Lower Respiratory Infection Group. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Crit Care Med 25 (1997) 1663-1670 Erratum in: Crit Care Med 1997;25:2067
5. Schmutzhard E., Williams K.J., Vukmirovits G., Chmelik V., Pfausler B., Featherstone A., and Meropenem Meningitis Study Group. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. J Antimicrob Chemother 36 Suppl. A (1995) 85-97
6. Klugman K.P., Dagan R., and Meropenem Meningitis Study Group. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother 39 (1995) 1140-1146
7. Calandra G., Lydick E., Carrigan J., Weiss L., and Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Am J Med 84 (1988) 911-918
8. Cunha B.A. Meropenem in elderly and renally impaired patients. Int J Antimicrob Agents 11 (1999) 167-177
9. Eldridge R., Iivanainen M., Stern R., Koerber T., and Wilder B.J. 'Baltic' myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 2 (1983) 838-842